Biomarkers of cardiometabolic risk in obese/overweight children: Effect of lifestyle intervention

Physiological Research

Volumn 63, Issue 6, 2014, Pages 743-752

  Vrablik M ^a   Dobiasova M ^b   Zlatohlavek L ^a   Urbanova Z ^c   Ceska R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

AIP Log(TG HDL C) ; ApoB apoAI ratio; Cardiometabolic risk markers; HOMA IR (insulin resistance); Intensive lifestyle intervention; Overweight obese children

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER;

ADOLESCENT; CHILD; FEMALE; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MALE; METABOLISM; OBESITY; OVERWEIGHT; PROCEDURES; RISK ASSESSMENT; SEXUAL DEVELOPMENT; TREATMENT OUTCOME;

ADOLESCENT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MALE; OBESITY; OVERWEIGHT; RISK ASSESSMENT; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 84920448069     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. CAMPOS H, GENEST JJ JR, BLIJLEVENS E, MCNAMARA JR, JENNER JL, ORDOVAS JM: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12: 187-195, 1992.
2. CANAS JA, SWEETEN S, BALAGOPAL PB: Biomarkers for cardiovascular risk in children. Curr Opin Cardiol 28: 103-114, 2013.
3. HDL). Clin Biochem 34: 583-588, 2001.
4. DOBIáŠOVá M, URBANOVá Z, RAUCHOVá H, ŠAMáNEK M, FROHLICH J: High-density lipoprotein subclasses and esterification rate of cholesterol in children: effect of gender and age. Acta Paediatr 87: 918-923, 1998.
5. HDL) and logarithmically transformed ratio of triglycerides to HDL-cholesterol. Physiol Res 50: 1-8, 2001.
6. DOBIáŠOVá M, FROHLICH J, ŠEDOVá M, CHEUNG MC, BROWN BG: Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res 52: 566-571, 2011.
7. FROHLICH J, DOBIáŠOVá M: Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-C are powerful predictors of positive findings on coronary angiography. Clin Chem 49: 1873-1880, 2003.
8. JEYARAJAH EJ, CROMWELL WC, OTVOS EJ: Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26: 847-870, 2006.
9. JUONALA M, VIIKARI JS, KäHöNEN M, SOLAKIVI T, HELENIUS H, JULA A, MARNIEMI J, TAITTONEN L, LAITINEN T, NIKKARI T, RAITAKARI OT: Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J Am Coll Cardiol 52: 293-299, 2008.
10. KIKUCHI DA, SRINIVASAN SR, HARSHA DW, WEBBER LS, SELLERS TA, BERENSON GS: Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study. Prev Med 21: 177-190, 1992.
11. th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001. Centr Eur Public Health 12: 126-130, 2004.
12. KURTOĞLU S, HATIPOĞLU N, MAZICIOĞLU M, KENDIRICI M, KESKIN M, KONDOLOT M: Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2: 100-106, 2010.
13. KWITEROVICH PO JR: Plasma lipid and lipoprotein levels in childhood. Ann NY Acad Sci 623: 90-107, 1991.
14. MOTYKOVA E, ZLATOHLAVEK L, PRUSIKOVA M, LANSKA V, CESKA R, VASICKOVA L, VRABLIK M: Lifestyle modification induced weight loss and changes of cardiometabolic risk factors including lowering of inflammatory response in obese children. Neuro Endocrinol Lett 32: 55-59, 2011.
15. MURGUíA-ROMERO M, JIMéNEZ-FLORES JR, SIGRIST-FLORES SC, ESPINOZA-CAMACHO MA, JIMéNEZMORALES M, PIñA E, MENDEZ-CRUZ AR, VILLALOBOS-MOLINA R, REAVEN GM: Triglyceride/high-density lipoprotein cholesterol ratio, insulin resistance, and cardio-metabolic risk in young men and women. J Lipid Res 54: 2795-2799, 2013.
16. MUSSO C, GRAFFIGNA M, SOUTELO J, HONFI M, LEDESMA L, MIKSZTOWICZ V, HONFI M, LEDESMA L, MIKSZTOWICZ V, PAZOS M, MIGLIANO M, SCHREIER LE, BERG GA: Cardiometabolic risk factors as apolipoprotein B, triglyceride/HDL-cholesterol ratio and C-reactive protein, in adolescents with and without obesity: cross-sectional study in middle class suburban children. Pediatr Diabetes 12: 229-234, 2011.
17. ONAT A, CAN G, KAYA H, HERGENC G: Atherogenic index of plasma (log10 triglyceride/high-density lipoproteidcholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 4: 89-98, 2010.
18. RAŠLOVá K, DOBIáŠOVá M, HUBáČEK JA, BENCOVá D, SIVáKOVá D, DANKOVá Z, FRANEKOVá J, JABOR A, GAŠPAROVIČ J, VOHNOUT B: association of metabolic and genetic factors with cholesterol esterification rate in HDL plasma and atherogenic index of plasma in a 40 years old slovak population. Physiol Res 60: 785-795, 2011.
19. REAVEN G: Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol 32: 1754-1759, 2012.
20. ŠAMáNEK M, URBANOVá Z: Occurrence of overweight and obesity in 7,427 Czech children examined in 2006 (in Czech). Ces-slov Pediat 63: 120-126, 2008.
21. SELLERS EA, SINGH GR, SAYERS SM: Apo-B/AI ratio identifies cardiovascular risk in childhood: the Australian Aboriginal Birth Cohort study. Diab Vasc Dis Res 6: 94-99, 2009.
22. SIERRA-JOHNSON J, ROMERO-CORRAL A, SOMERS VK, LOPEZ-JIMENEZ F, WALLDIUS G, HAMSTEN A, HELLéNIUS ML, FISHER RM: ApoB/apoA-I ratio: an independent predictor of insulin resistance in US nondiabetic subjects. Eur Heart J 28: 2637-2643, 2007.
23. SOLHPOUR A, PARKHIDEH S, SARRAFZADEGAN N, ASGARY S, WILLIAMS K, JUNGNER I, AASTVEIT A, WALLDIUS G, SNIDERMAN A: Levels of lipids and apolipoproteins in three cultures. Atherosclerosis 207: 200-207, 2009.
24. TAN MH, JOHNS D, GLAZER NB: Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem 50: 1184-1188, 2004.
25. THOMPSON A, DANESH J: Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 259: 481-492, 2006.
26. TRESACO B, BUENO G, PINEDA I, MORENO LA, GARAGORRI JM, BUENO M: Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children. J Physiol Chem 61: 381-388, 2005.
27. URBINA EM, KHOURY PR, MCCOY CE, DOLAN LM, DANIELS SR, KIMBALL TR: Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. J Pediatr 158: 715-721, 2011.
28. WALLDIUS G, JUNGNER I, HOLME I, AASTVEIT AH, KOLAR W, STEINER E: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358: 2026-2033, 2001.